awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39696831-95E09E44-8C66-4178-8D27-6870AB9F9AC8
Q39696831-95E09E44-8C66-4178-8D27-6870AB9F9AC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39696831-95E09E44-8C66-4178-8D27-6870AB9F9AC8
Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir.
P2860
Q39696831-95E09E44-8C66-4178-8D27-6870AB9F9AC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39696831-95E09E44-8C66-4178-8D27-6870AB9F9AC8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32fa9aeab7a3897bd7e2e9758c991180911562b6
P2860
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.